The effect of carboxytherapy in the treatment of stress urinary incontinence and sexual dysfunctio

Phase 3

• Conditions: Condition 1: Sexual dysfunction. Condition 2: Stress urinary incontinence.; Sexual dysfunction not due to a substance or known physiological condition; Stress incontinence; N39.3

• Registration Number: IRCT20200825048515N27
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

women with stress urinary incontinence or sexual dysfunction
within the age range of 35-65 years
Have at least one vaginal delivery or cesarean section

Exclusion Criteria

Having active vaginal bleeding
Having vaginal infection
Having abnormal Pap smear
Pregnancy
Having urinary tract infection
Recent pelvic surgery
Having grade 2 or more pelvic organ prolapse
Treatment with antiplatelet or anticoagulant drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
rinary stress incontinence score. Timepoint: Before, one and three months after the intervention. Method of measurement: Questionnaire-Urinary Incontinence Short Form(ICIQ-UI SF).;Sexual dysfunction score. Timepoint: Before, one and three months after the intervention. Method of measurement: Short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12).